3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
15
Neoplasm Metastasis
11
Ovarian Neoplasms
9
Pancreatic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Stomach Neoplasms
6
Skin Neoplasms
6
Leukemia, Myeloid, Acute
6
Colorectal Neoplasms
6
Carcinoma, Renal Cell
6
Triple Negative Breast Neoplasms
4
Gastrointestinal Neoplasms
4
Breast Neoplasms
4
Vulvar Neoplasms
3
Uterine Cervical Neoplasms
3
Urogenital Neoplasms
3
Rectal Neoplasms
3
Neuroblastoma
3
Myelodysplastic Syndromes
3
Multiple Myeloma
3
Leukemia
3
Colonic Neoplasms
3
Vaginal Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pleural Effusion, Malignant
2
Penile Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Interventions
Magnetic Resonance Spectroscopy
9
Cyclophosphamide
7
X-Rays
6
Temozolomide
6
Specimen Handling
6
Phantoms, Imaging
6
Biopsy
6
Nuclear Medicine Department, Hospital
5
Etoposide
5
Nivolumab
4
Bevacizumab
4
Radiation
3
Irinotecan
3
Automobiles
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
lutetium Lu 177 dotatate
2
larotrectinib
2
ivosidenib
2
etoposide phosphate
2
erdafitinib
2
ensartinib
2
abemaciclib
2
Watchful Waiting
2
Radiotherapy
2
ONC206
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ependymoma
×
aldesleukin
×
1 year
×
Clear all
No trials found.